A Multicentre phase 3 randomised trial comparing docetaxel administered either weekly or every three weeks in combination with prednisolone versus mitoxantrone incombination with prenisolone for metaststic hormonr refractory prostate cancer

Short title	A Multicentre phase 3 randomised trial comparing docetaxel administered either weekly or every three weeks in combination with prednisolone versus mitoxantrone incombination with prenisolone for metaststic hormonr refractory prostate cancer
Status	Finished
Effective start/end date	18/12/00 → 17/12/04

Project Details